AG Ventures LtdQ2 FY24

AG Ventures Ltd Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹129.2P/E: 5.7Market Cap: ₹128 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • The company expects volume growth to be better in H2 FY '24 compared to H1, aiming to improve upon Q2 sales quantities.
  • They target increasing global market share from current 10% to 12% by end of calendar year 2024, driven by expansion in North America, new customers, and increased domestic market share.
  • Plans to fully utilize current capacities over the next 2-3 years before considering further expansion.
  • Domestic market demand is expected to grow robustly due to automotive industry growth, increased use of commercial vehicles, radialization of commercial tires, and government infrastructure projects.
  • They aim for flattish to positive volume growth for full FY '24 compared to FY '23, hoping not to be down overall.
  • Capacity utilization is expected to improve with appropriate allocations, which were a bottleneck previously.
  • Limited capacity additions expected in the near term, with only a Japanese competitor planning a 10,000 MT expansion.

See what AG Ventures Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no explicit mention of any current or planned new fundraising through debt or equity in the transcript.
  • The company has focused on reducing debt by prepaying INR25.5 crores in the first half of FY '24 and expects to reduce further by about INR10.5 crores by the end of the year.
  • Long-term debt has already decreased from INR104.09 crores at the beginning of the year to INR78.5 crores as of September 30, 2023.
  • No announcements or discussions related to raising additional funds through equity or fresh debt were made during the call.
  • The management emphasizes utilizing current capacities and improving market share rather than expansion through fresh capital at this stage.

See what AG Ventures Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes
- No new orders have been received for the recent capacity expansion, so there is no immediate ramp-up planned. - The company aims to increase capacity utilization of existing capacities first over the next 2-3 years before considering further expansion. - A Japanese competitor has declared a 10,000 metric tons capacity expansion plan, but no other players, including Flexsys, have indicated capacity expansion to OCCL's knowledge. - Management hopes that demand growth and geopolitical stability will ease pressure on capacity utilization, limiting the need for immediate expansion. - The company has approvals in place to sell out its entire current capacity but depends on allocations to achieve that. Overall, OCCL is focusing on better utilization of existing capacity before making new capital investments.

Track AG Ventures Ltd — get its next earnings analysis in your feed

How does AG Ventures Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisAG Ventures Ltd
Rev 4Mar 3

How does AG Ventures Ltd rank in Chemicals & Petrochemicals?

Compare AG Ventures Ltd against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Neogen Chemicals Ltd (Q2 FY27)

    Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how

  • Mahickra Chemicals Ltd (Q2 FY27)

    682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Vishnu Chemicals Ltd (Q2 FY27)

    2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Yasons Chemex (Q2 FY27)

    4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →